![Palatin Technologies Inc New](/common/images/company/A_PTN.png)
Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the me... Palatin Technologies Inc is a part of the healthcare sector. The company is engaged in developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with unmet medical needs and commercial potential. Its programs are based on molecules that modulate the activity of the melanocortin and natriuretic peptide receptor systems. Its main product in clinical development is bremelanotide, which treats hypoactive sexual desire disorder, which is a type of female sexual dysfunction. Show more
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.02 | -1.19047619048 | 1.68 | 1.87 | 1.61 | 110987 | 1.72347959 | CS |
4 | -0.22 | -11.7021276596 | 1.88 | 1.96 | 1.61 | 85366 | 1.74678477 | CS |
12 | -0.42 | -20.1923076923 | 2.08 | 2.48 | 1.61 | 107718 | 1.97490365 | CS |
26 | -3.47 | -67.6413255361 | 5.13 | 5.22 | 1.46 | 391454 | 2.40002368 | CS |
52 | -0.23 | -12.1693121693 | 1.89 | 5.65 | 1.43 | 296042 | 2.58065689 | CS |
156 | 1.15 | 225.490196078 | 0.51 | 8.6 | 0.1811 | 1143803 | 0.81123018 | CS |
260 | 0.7263 | 77.7872978473 | 0.9337 | 8.6 | 0.1811 | 1622881 | 0.75659476 | CS |
Symbol | Price | Vol. |
---|---|---|
SOXLDirexion Daily Semiconductor Bull 3X Shares | $ 42.63 (14.47%) | 36.38M |
SOXSDirexion Daily Semiconductor Bear 3X Shares New | $ 25.07 (-14.55%) | 20.87M |
TELLTellurian Inc | $ 0.9249 (-0.28%) | 17.88M |
SPXSDirexion Daily S&P 500 Bear 3X Shares New | $ 7.6082 (-5.25%) | 12.66M |
TZADirexion Daily Small Cap Bear 3X Share New | $ 13.62 (-1.52%) | 12.34M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.